119 related articles for article (PubMed ID: 31481635)
1. β
Ingebrigtsen TS; Vestbo J; Rode L; Marott JL; Lange P; Nordestgaard BG
Thorax; 2019 Oct; 74(10):934-940. PubMed ID: 31481635
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
4. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
5. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
6. Beta
Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
[TBL] [Abstract][Full Text] [Related]
7. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
8. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
Çolak Y; Afzal S; Lange P; Nordestgaard BG
Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
[TBL] [Abstract][Full Text] [Related]
9. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
11. β
Karimi L; Lahousse L; Ghanbari M; Terzikhan N; Uitterlinden AG; van der Lei J; Brusselle GG; Stricker BH; Verhamme KMC
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683975
[TBL] [Abstract][Full Text] [Related]
12. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
15. Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.
Emeryk-Maksymiuk J; Emeryk A; Krawczyk P; Wojas-Krawczyk K; Milanowski J
Pulm Pharmacol Ther; 2017 Apr; 43():1-5. PubMed ID: 28093224
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
17. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists.
Petrovic-Stanojevic N; Topic A; Nikolic A; Stankovic M; Dopudja-Pantic V; Milenkovic B; Radojkovic D
Mol Diagn Ther; 2014 Dec; 18(6):639-46. PubMed ID: 25074500
[TBL] [Abstract][Full Text] [Related]
19. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in scavenger and β₂-adrenergic receptors and risk of pulmonary disease.
Thomsen M
Dan Med J; 2014 Sep; 61(9):B4910. PubMed ID: 25186548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
